The Centre quarterly newsletter, June 2025 issue, is now available.
In this issue:
Centre’s…
EU-Japan Biotech & Pharma Partnering Conference
24
Sep
2025
Pharmaceuticals
Farmaforum 2024 Brokerage Event
Over a decade, Farmaforum has consolidated its position as the most relevant event of the Pharmaceutical Industry in Spain.
Italy Pavillion at CPHI Japan 2025 - Convention of Pharmaceutical Ingredients
The Italian Trade Promotion Section in Tokyo coordinates the participation of 19 leading pharmaceutical companies at CPhI Japan 2025, reinforcing Italy’s role as a top supplier of active pharmaceutical ingredients and cutting-edge solutions.
“About Japan” reports and webinars
New reports and webinars are provided as part of the Centre’s support for EU Business in Japan. This section provides valuable information for European Union companies seeking clear guidelines for trading, investing, or partnering with Japanese entities.
Five days in Japan filled with opportunities in Biotech & Pharma
On 7-12 October, the EU-Japan Centre for Industrial Cooperation organised its annual business mission in the Life Sciences field. 10 SMEs from 7 EU countries participated in the 5-day mission.
Biotech Business Mission
06
Oct
2025
HYBRID MATCHMAKING EVENT
24
Sep
2024
Call for Open Innovation Program “MOIRe” 2024
MOIRe is an annual open innovation research program for drug discovery initiated by Mochida Pharmaceutical Co., Ltd, a large Japanese pharmaceutical company. Application form and more detailed information available online.
EU-Japan Biotech & Pharma Partnering Conference is open for registration
In September and October this year, the EU-Japan Biotech & Pharma Partnering Conference will once again bring together biotech and pharma companies from Europe and Japan, both online and on-site in Osaka, Japan.
Innovative Therapies Days
CCI Région Bourgogne Franche-Comté is organizing a B2B matching event within the frame of the scientific congress Innovative Therapies Days.
Mochida Pharmaceutical’s open innovation programme
Since 2019, the company is managing its MOIRe (Mochida Open Innovation Research) programme and is now inviting researchers and research representatives affiliated with public research institutions, universities, etc. to submit proposals for collaborative research.
News from EU-Japan Business Round Table’s member NEC Japan establishes European subsidiaries to strengthen its work on AI drug development
NEC strengthens its European life science activities where AI technology, biomedical science and ICT combine to develop advanced therapies for patients across the globe. Central and Northern Europe’s vivid entrepreneurial and scientific environment, and the European clinical network and regulatory infrastructure, help drive developments in immunotherapies.
